230 related articles for article (PubMed ID: 18249218)
1. RGS2 C1114G polymorphism and body weight gain in hypertensive patients.
Sartori M; Ceolotto G; Dorigatti F; Mos L; Santonastaso M; Bratti P; Papparella I; Semplicini A; Palatini P;
Metabolism; 2008 Mar; 57(3):421-7. PubMed ID: 18249218
[TBL] [Abstract][Full Text] [Related]
2. Reduced expression of regulator of G-protein signaling 2 (RGS2) in hypertensive patients increases calcium mobilization and ERK1/2 phosphorylation induced by angiotensin II.
Semplicini A; Lenzini L; Sartori M; Papparella I; Calò LA; Pagnin E; Strapazzon G; Benna C; Costa R; Avogaro A; Ceolotto G; Pessina AC
J Hypertens; 2006 Jun; 24(6):1115-24. PubMed ID: 16685212
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism C1114G of gene encoding the cardiac regulator of G-protein signaling 2 may be associated with number of episodes of neurally mediated syncope.
Lelonek M; Pietrucha T; Matyjaszczyk M; Goch JH
Arch Med Res; 2009 Apr; 40(3):191-5. PubMed ID: 19427970
[TBL] [Abstract][Full Text] [Related]
4. Rebound weight gain as associated with high plasma norepinephrine levels that are mediated through polymorphisms in the beta2-adrenoceptor.
Masuo K; Katsuya T; Kawaguchi H; Fu Y; Rakugi H; Ogihara T; Tuck ML
Am J Hypertens; 2005 Nov; 18(11):1508-16. PubMed ID: 16280290
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 g.-174G>C promoter polymorphism is associated with obesity in the EPIC-Potsdam Study.
Klipstein-Grobusch K; Möhlig M; Spranger J; Hoffmann K; Rodrigues FU; Sharma AM; Klaus S; Pfeiffer AF; Boeing H
Obesity (Silver Spring); 2006 Jan; 14(1):14-8. PubMed ID: 16493118
[TBL] [Abstract][Full Text] [Related]
6. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
Othman M; Kawar B; El Nahas AM
Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in the NPY and AGRP genes and body fatness in Dutch adults.
van Rossum CT; Pijl H; Adan RA; Hoebee B; Seidell JC
Int J Obes (Lond); 2006 Oct; 30(10):1522-8. PubMed ID: 16568137
[TBL] [Abstract][Full Text] [Related]
8. beta(3) Adrenergic receptor polymorphism and obesity-related phenotypes in hypertensive patients.
Hao K; Peng S; Xing H; Yu Y; Huang A; Hong X; Wang Y; Chen C; Wang B; Zhang X; Liu J; Zhu G; Huo Y; Chen D; Zhao X; Ronnenberg A; Wu D; Niu T; Xu X
Obes Res; 2004 Jan; 12(1):125-30. PubMed ID: 14742851
[TBL] [Abstract][Full Text] [Related]
9. Studies of associations between the Arg389Gly polymorphism of the beta1-adrenergic receptor gene (ADRB1) and hypertension and obesity in 7677 Danish white subjects.
Gjesing AP; Andersen G; Albrechtsen A; Glümer C; Borch-Johnsen K; Jørgensen T; Hansen T; Pedersen O
Diabet Med; 2007 Apr; 24(4):392-7. PubMed ID: 17335470
[TBL] [Abstract][Full Text] [Related]
10. Natriuretic peptide clearance receptor alleles and susceptibility to abdominal adiposity.
Sarzani R; Strazzullo P; Salvi F; Iacone R; Pietrucci F; Siani A; Barba G; Gerardi MC; Dessì-Fulgheri P; Rappelli A
Obes Res; 2004 Feb; 12(2):351-6. PubMed ID: 14981229
[TBL] [Abstract][Full Text] [Related]
11. Preproghrelin Leu72Met variant contributes to overweight in middle-aged men of a Japanese large cohort.
Kuzuya M; Ando F; Iguchi A; Shimokata H
Int J Obes (Lond); 2006 Nov; 30(11):1609-14. PubMed ID: 16865101
[TBL] [Abstract][Full Text] [Related]
12. RGS2 expression and aldosterone: renin ratio modulate response to drug therapy in hypertensive patients.
Semplicini A; Strapazzon G; Papparella I; Sartori M; Realdi A; Macchini L; Calò LA; Ceolotto G
J Hypertens; 2010 May; 28(5):1104-8. PubMed ID: 20375904
[TBL] [Abstract][Full Text] [Related]
13. Hypertension, obesity and GNB 3 gene variants.
Danoviz ME; Pereira AC; Mill JG; Krieger JE
Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):248-52. PubMed ID: 16487269
[TBL] [Abstract][Full Text] [Related]
14. Beta2- and beta3-adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5 years.
Masuo K; Katsuya T; Fu Y; Rakugi H; Ogihara T; Tuck ML
Circulation; 2005 Jun; 111(25):3429-34. PubMed ID: 15956122
[TBL] [Abstract][Full Text] [Related]
15. G protein beta3 subunit gene polymorphism in Turkish hypertensives.
Alioğlu E; Ercan E; Tengiz I; Yildiz A; Onsel Türk U; Saygi S; Cam FS; Berdeli A
Anadolu Kardiyol Derg; 2008 Oct; 8(5):331-5. PubMed ID: 18849222
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E gene polymorphism and obesity status in middle-aged men with coronary heart disease.
Kolovou GD; Anagnostopoulou KK; Kostakou P; Giannakopoulou V; Mihas C; Hatzigeorgiou G; Vasiliadis IK; Mikhailidis DP; Cokkinos DV
In Vivo; 2009; 23(1):33-9. PubMed ID: 19368122
[TBL] [Abstract][Full Text] [Related]
17. Anthropometric and metabolic phenotypes in relation to the ADRA2B deletion/insertion polymorphism in Chinese population.
Li LH; Li Y; Wen Y; Wang JG
J Hypertens; 2008 Nov; 26(11):2161-7. PubMed ID: 18854756
[TBL] [Abstract][Full Text] [Related]
18. Obesity paradox in patients with hypertension and coronary artery disease.
Uretsky S; Messerli FH; Bangalore S; Champion A; Cooper-Dehoff RM; Zhou Q; Pepine CJ
Am J Med; 2007 Oct; 120(10):863-70. PubMed ID: 17904457
[TBL] [Abstract][Full Text] [Related]
19. beta2- and beta3-Adrenoceptor polymorphisms relate to subsequent weight gain and blood pressure elevation in obese normotensive individuals.
Kawaguchi H; Masuo K; Katsuya T; Sugimoto K; Rakugi H; Ogihara T; Tuck ML
Hypertens Res; 2006 Dec; 29(12):951-9. PubMed ID: 17378367
[TBL] [Abstract][Full Text] [Related]
20. Investigation of 3111T/C polymorphism of the CLOCK gene in obese individuals with or without binge eating disorder: association with higher body mass index.
Monteleone P; Tortorella A; Docimo L; Maldonato MN; Canestrelli B; De Luca L; Maj M
Neurosci Lett; 2008 Apr; 435(1):30-3. PubMed ID: 18314271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
